Błachut, D; Wojtasiewicz, K; Czarnocki, Z; Szukalski, B. The analytical profile of some 4-methylthioamphetamine (4-MTA) homologues. Forensic Sci. Int., 20 Nov 2009, 192 (1–3), 98–114. 683 kB. https://doi.org/10.1016/j.forsciint.2009.08.009
Cloonan, SM; Keating, JJ; Corrigan, D; O’Brien, JE; Kavanagh, PV; Williams, DC; Meegan, MJ. Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted α-alkylthioamphetamines. Bioorg. Med. Chem., 1 Jun 2010, 18 (11), 4009–4031. 1.2 MB. https://doi.org/10.1016/j.bmc.2010.04.022
Cloonan, SM; Keating, JJ; Butler, SG; Knox, AJS; Jørgensen, AM; Peters, GH; Rai, D; Corrigan, D; Lloyd, DG; Williams, DC; Meegan, MJ. Synthesis and serotonin transporter activity of sulphur-substituted α-alkyl phenethylamines as a new class of anticancer agents. Eur. J. Med. Chem., 1 Dec 2009, 44 (12), 4862–4888. 1.2 MB. https://doi.org/10.1016/j.ejmech.2009.07.027
Hurtado-Guzmán, C; Fierro, A; Iturriaga-Vásquez, P; Sepúlveda-Boza, S; Cassels, BK; Reyes-Parada, M. Monoamine oxidase inhibitory properties of optical isomers and N-substituted derivatives of 4-methylthioamphetamine. J. Enzyme Inhib. Med. Chem., 1 Aug 2003, 18 (4), 339–347. 149 kB. https://doi.org/10.1080/1475636031000118437 #NMMTA
Rothman, RB; Partilla, JS; Baumann, MH; Lightfoot-Siordia, C; Blough, BE. Studies of the biogenic amine transporters. 14. Identification of low-efficacy “partial” substrates for the biogenic amine transporters. J. Pharmacol. Exp. Ther., 1 Apr 2012, 341 (1), 251–262. 2.2 MB. https://doi.org/10.1124/jpet.111.188946 #PAL-1062